SC refuses to entertain plea against Madras HC order on Patanjali’s use of Coronil

The Supreme Court on August 27 refused to entertain a plea filed by Arudra Engineers challenging the order of the Division bench of Madras High Court’s order which stayed the single bench order restraining Patanjali Ayurved from using the trademark ‘Coronil’.

A bench of Chief Justice SA Bobde and Justices AS Bopanna & V. Ramasubramaniun allowed the petitioner(s) to withdraw the plea and stated that the petitioners had the liberty to pursue the case bfore the Madras High Court.
 

According to CJI SA Bobde, if the use of word “Coronil” is prevented only because there is some pesticide bearing the same name, it will be terrible for the product.

The firm – Arudra Engineers has claimed that it owns and has been using the trademark - ‘Coronil’ since 1993. The company’s registered trademark, called ‘CORONIL-92 B’, is an acid inhibitor used for industrial purposes.

The Petitioner has assailed an order passed by the Division bench of Madras High Court which had issued an interim stay on the single bench order restraining Patanjali Ayurved and Divya Yog Mandir Trust from using the word “Coronil” in relation to its immunity-boosting products.

In July, the Madras High Court had granted interim injunction against Patanjali Ayurved Limited from using the trademark ‘Coronil’ for their immunity booster drug.

On August 6, a single bench of Justice C V Karthikeyan passed an absolute injunction order, restraining it from using the trademark ‘Coronil’, observing that Patanjali was utilizing the public fear for their advantage by projecting that they could cure COVID-19.